Cytoblastin 10 mg (Vinblastine Sulphate) Quantity:3 Injection/s This specialized formulation is ideally

This specialized formulation is ideally balanced for routine cases

the most common of which include hand‑foot skin reaction

\nA: Individuals with severe renal impairment (creatinine clearance <30 mL/min) should avoid this medication unless dose‑adjusted under medical supervision

com entry on Donepezil

It is a much higher-strength formulation and should be used only under medical supervision

Cytoblastin 10 mg (Vinblastine Sulphate) Quantity:3 Injection/s This specialized formulation is ideallyProduct Overview \nCytoblastin 10 mg is a sterile injectable formulation containing vinblastine sulphate, a potent microtubuledestabilizing agent classified as a vinca alkaloid. Manufactured by Cipla Limited, the medication is supplied in a singleuse vial containing 10 ml of solution intended for intravenous administration. The drug is indicated for the treatment of several solid tumours, most notably breast cancer, renal cell carcinoma, and Hodgkins